Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy

Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy

US Patent 5681927 · Granted Oct 28, 1997

Estimated economic value: $1,850,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use the2015
F-18 radiolabeled compounds for diagnosing and monitoring kidney function2014
Substituted 4-(selenophen-2(or-3)-ylamino)pyrimidine compounds and methods of us2014
Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma an2012
Anti-cancer drugs, and uses relating for malignant melanoma and other cancers2012
Radiolabeled annexins2010
Radiolabeled annexins2010
High dose radionuclide complexes for bone marrow treatment2010
Skeletal-targeted radiation to treat bone-associated pathologies2010
Bridged aromatic substituted amine ligands with donor atoms2010
Peptide-chelate conjugates2009
Skeletal-targeted radiation to treat bone-associated pathologies2009